HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.2 CNY | +0.09% |
|
-7.44% | -13.91% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hebei Changshan Biochemical Pharmaceutical Co., Ltd is principally engaged in the research, development, manufacture and distribution of bio-pharmaceutical products. The Company primarily provides heparin product series. The Company provides sodium heparin active pharmaceutical ingredients (APIs) and hydro-acupuncture preparations. The Company's products are applied primarily in the prevention and treatment of cerebral vascular diseases, hardened arteries, myocardial infarction and phlebitis, among others. It distributes its products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-20
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.91% | 1.42B | |
| -1.15% | 89.37B | |
| +2.76% | 40.65B | |
| -12.32% | 32.81B | |
| +52.41% | 25B | |
| -17.39% | 15.29B | |
| -42.45% | 11.61B | |
| -10.48% | 11.49B | |
| +6.14% | 8.98B | |
| -7.72% | 8.23B |
- Stock Market
- Equities
- 300255 Stock
- News Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Changshan Biochemical Pharma Registers Enoxaparin Sodium Injection in Nicaragua
